首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1622751

全球支架移植物用球囊導管市場規模（按產品、應用、地區、範圍和預測）

Global Stent Graft Balloon Catheter Market Size By Product, By Application, By Geographic Scope And Forecast

出版日期: 2024年09月13日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

支架移植物球囊導管的市場規模及預測

近年來，支架移植物用球囊導管的市場規模一直以中等速度成長，成長率顯著，預計 2024 年至 2031 年間將大幅成長。

支架移植物球囊導管的全球市場驅動因子

支架移植物球囊導管市場的市場推動因素受到多種因素的影響。

血管疾病盛行率不斷上升

隨著血管疾病（包括週邊動脈疾病、主動脈瘤和其他心血管疾病）的發生率不斷上升，對支架移植物球囊導管的需求也隨之增加。此類設備對於有效治療這些疾病是必要的。

老年人口不斷增加：

隨著世界人口老化，人們更容易受到血管疾病及其影響，增加了對球囊導管和支架移植等醫療程序的需求。這些設備通常是老年人成功進行血管治療所必需的。

醫療科技的進步：

由於醫療技術的不斷進步，包括開發採用更好的材料、更卓越的設計和功能的先進支架移植物球囊導管，該市場正在不斷增長。這些發展使得程序更加安全、有效率和簡單。

越來越多的患者和醫療保健專業人員選擇微創手術，因為它具有恢復更快、併發症更少、住院時間更短的優點。用於支架移植的球囊導管對於這些微創血管治療至關重要。

提高對血管疾病的認識與辨識：

隨著人們對疾病認識的提高和診斷工具的進步，早期發現和治療血管疾病成為可能。因此，接受早期診斷和早期治療的患者數量將會增加，從而增加對支架移植物球囊導管的需求。

影像與診斷技術的發展：

CT、MRI 和超音波等影像技術的進步使得支架移植物球囊導管的準確診斷和精確放置成為可能。改進的診斷成像將改善治療結果並鼓勵使用這些設備。

優惠的付款政策：

如果國家和私人保險公司對支架移植手術等血管介入治療提供優惠的支付政策，那麼會有更多的患者選擇支架移植手術等血管介入治療。這促使支架移植手術中使用的球囊導管的需求增加。

增加醫療支出：

醫療保健支出的增加，尤其是在新興國家，正在改善獲得尖端醫療程序和設備的機會。隨著醫療服務和基礎設施支出的增加，支架移植物球囊導管市場正在擴大。

血管手術數量不斷增加：

隨著血管問題變得越來越普遍，對支架移植球囊導管的需求也日益增加。支架移植物用的球囊導管是達到良好手術效果的重要工具。

限制全球支架移植物球囊導管市場的因素

有幾個因素可能會對支架移植物球囊導管市場造成限制和課題。

昂貴的手術：

與傳統手術相比，使用球囊導管進行支架移植的微創手術費用昂貴。高昂的手術費用會限制患者的手術治療，特別是在保險覆蓋和醫療資源有限的地區。

兌換難度：

微創手術的報銷指南可能因地區和醫療保健系統而異。由於不確定性以及支付率和承保範圍指南的變化，支架移植物球囊導管的引入可能會對醫療保健提供者產生影響。

監理障礙：

美國 FDA 和歐洲 CE 標誌等醫療機構對支架移植物用球囊導管制定了嚴格的規定。獲得監管部門的批准成本高昂且耗時，這可能會延遲新產品的上市。

臨床資料需求

儘管支架移植物球囊導管的安全性和有效性已得到證實，但監管機構和醫療保健提供者經常需要可靠的臨床數據來支持這一說法。臨床試驗可能需要大量時間和資源來產生足夠的數據。

技術複雜性：

製造一種稱為支架移植物球囊導管的複雜醫療設備需要先進的工程和製造方法。以監管的方式開發和製造這些醫療設備非常困難且成本高昂。

產品召回與安全問題：

與支架移植物球囊導管有關的不良事件、產品召回和安全問題可能會削弱消費者信心並引起監管機構的注意。為了使產品被市場接受和發展，必須保持產品的品質和安全。

與替代療法競爭：

球囊導管支架移植的替代方案包括傳統開放性手術、藥物治療和其他微創療法。醫療保健專業人員可以根據臨床建議、患者俱體標準和財務限制選擇替代療法。

創新療法的報銷限制：

最初，付款人可能無法完全償還創新球囊導管療法的費用。這可能會阻止醫療保健提供者在支付指南最終確定之前採用新方法或設備。

教育與訓練要求

在微創手術中使用球囊導管進行支架移植物需要特殊的知識和訓練。缺乏技術熟練的醫生和培訓項目，尤其是在貧困地區和農村地區，可能會阻礙這些程序的採用。

全球供應鏈中斷：

貿易限制、自然災害和地緣政治衝突等事件都會影響醫療器材的全球供應鏈，包括支架移植的球囊導管。供應鏈中斷可能導致成本增加和產品交付延遲。

The market is growing due to ongoing improvements in medical technology, such as the creation of sophisticated stent graft balloon catheters with better materials, better designs, and increased functionality. Procedures are now safer, more efficient, and simpler to carry out thanks to these developments.

A increasing number of patients and healthcare professionals are choosing minimally invasive procedures because of its advantages, which include quicker recovery times, less problems, and shorter hospital stays. Balloon catheters for stent grafts are essential to these minimally invasive vascular treatments.

Growing Recognition and Identification of Vascular Illnesses:

Early detection and treatment of vascular disorders are made possible by greater awareness of the condition and advancements in diagnostic tools. As a result, more patients receive early diagnosis and treatment, which increases demand for stent graft balloon catheters.

Technological Developments in Imaging and Diagnostics:

Accurate diagnosis and precise implantation of stent graft balloon catheters are made possible by advancements in imaging technologies, including CT, MRI, and ultrasound. Improved imaging encourages greater therapy results and propels the use of these gadgets.

Advantageous payment Policies:

More patients choose vascular interventions, such as stent graft operations, when government and commercial insurance companies offer advantageous payment policies for these procedures. This increases the need for balloon catheters used in stent grafting.

Growing Healthcare Expenditure:

Access to cutting-edge medical procedures and equipment is improved by growing healthcare spending, especially in emerging nations. The market for stent graft balloon catheters is growing as a result of increased expenditure in healthcare services and infrastructure.

Growing Number of Vascular Surgeries:

As vascular problems become more common, there is a growing need for stent graft balloon catheters, which is being driven by the rising number of vascular surgeries conducted globally. These tools are essential for good surgical results.

Global Stent Graft Balloon Catheter Market Restraints

Several factors can act as restraints or challenges for the Stent Graft Balloon Catheter Market. These may include:

Expensive Procedures:

When compared to conventional surgeries, minimally invasive procedures utilising balloon catheters for stent grafts might be costly. Patient access may be restricted by the high cost of operations, particularly in areas with inadequate insurance coverage and healthcare resources.

Difficulties with Reimbursement:

Different geographic areas and healthcare systems may have different reimbursement guidelines for minimally invasive procedures. Healthcare practitioners' adoption of stent graft balloon catheters may be impacted by uncertainty or modifications to payment rates and coverage guidelines.

Regulatory Obstacles:

Health authorities like the FDA in the US and the CE marking procedure in Europe have strict regulations governing stent graft balloon catheters. Getting regulatory clearances may be expensive and time-consuming, which delays the introduction of new items onto the market.

Clinical data Requirements:

Stent graft balloon catheter safety and efficacy have been shown, and regulatory bodies and healthcare providers frequently need solid clinical data supporting this claim. Clinical studies might take a lot of time and resources to complete in order to produce enough data.

Technological Complexity:

Advanced engineering and manufacturing methods are needed to produce the sophisticated medical devices known as stent graft balloon catheters. It can be difficult and expensive to develop and manufacture these devices in compliance with regulatory regulations.

Product Recalls and Safety Concerns:

Stent graft balloon catheter-related adverse events, product recalls, and safety concerns can undermine customer trust and draw regulatory attention. For a product to be accepted and thrive in the market, quality and safety must be maintained.

Competition from Alternative Therapies:

Conventional open surgery, medicine, and other minimally invasive methods are some of the alternatives to stent graft balloon catheters. Healthcare professionals may select alternative therapies in accordance with clinical recommendations, patient-specific criteria, and financial constraints.

Limited Reimbursement for Innovative treatments:

At first, healthcare payers might not fully reimburse innovative treatments employing stent graft balloon catheters. This may discourage medical professionals from implementing novel methods and equipment until such time as payment guidelines are finalised.

Requirements for Education and Training:

Using stent graft balloon catheters for minimally invasive operations calls for specific knowledge and training. Adoption of these procedures may be hampered by limited access to skilled physicians and training programmes, especially in underprivileged or rural locations.

Disruptions to the Global Supply Chain:

Events like trade restrictions, natural catastrophes, and geopolitical conflicts can all have an impact on the global supply chain for medical equipment, including stent graft balloon catheters. Disruptions to the supply chain may result in higher expenses and product availability delays.

Segmentation Analysis

The Global Stent Graft Balloon Catheter Market is Segmented on the basis of Product Type, Application, End-User, and Geography.

Stent Graft Balloon Catheter Market, By Product Type

Non-Compliant Balloon Catheters:
Balloon catheters with a rigid structure designed for high-pressure dilatation of stent grafts.
Compliant Balloon Catheters:
Balloon catheters with a flexible structure designed to conform to the shape of the vessel during dilatation.
Semi-Compliant Balloon Catheters:
Balloon catheters with intermediate properties between non-compliant and compliant balloons, offering a balance between rigidity and flexibility.

Stent Graft Balloon Catheter Market, By Application

Endovascular Aneurysm Repair (EVAR):
Treatment of abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA) using stent grafts delivered via balloon catheters.
Thoracic Endovascular Aneurysm Repair (TEVAR):
Treatment specifically targeting thoracic aortic aneurysms.
Peripheral Vascular Interventions:
Treatment of peripheral artery diseases (PAD) and other vascular conditions using stent grafts delivered via balloon catheters.
Other Applications:
Including treatment of arteriovenous (AV) fistulas, venous stenosis, and other vascular conditions.

Stent Graft Balloon Catheter Market, By

End-User
Hospitals:
Major healthcare facilities where endovascular procedures are commonly performed.
Ambulatory Surgical Centers (ASCs):
Outpatient centers specializing in minimally invasive procedures, including endovascular interventions.
Specialty Clinics:
Clinics focusing on vascular health and interventions.
Others:
Including academic and research institutions involved in clinical trials and studies related to endovascular treatments.

Stent Graft Balloon Catheter Market, By Geography

North America:
Includes the United States and Canada, characterized by advanced healthcare infrastructure and high adoption of endovascular procedures.
Europe:
Includes countries such as Germany, the UK, France, Italy, and Spain, with strong healthcare systems and a growing prevalence of vascular diseases.
Asia-Pacific:
Includes China, Japan, India, South Korea, and Australia, where increasing healthcare investments and a rising aging population drive market growth.
Latin America:
Includes Brazil, Mexico, and other countries in Central and South America, with emerging healthcare markets.
Middle East and Africa:
Includes countries such as Saudi Arabia, UAE, South Africa, and others, where there is growing investment in healthcare infrastructure and a rising prevalence of cardiovascular diseases.

Key Players

The "Global Stent Graft Balloon Catheter Market" study report will provide a valuable insight with an emphasis on the global market. The major players in the market are
Jotech, Terumo, Boston Scientific, MicroPort Scientific, Cardionovum, Hexacath, Meril Life Sciences, Medtronic Plc, Cordis Corporation, B. Braun Melsungen AG, Cook Medical Inc, Terumo Corporation, Abbott Laboratories and Boston Scientific Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.